CollPlant Biotechnologies (CLGN) Q4 2025 Earnings — Miss Estimates

Screener

Reported March 26, 2026 · Before market open

Revenue$60.0KMiss by $2.0M

EPS-$0.67Miss by $0.37

Revenue estimate$2.1M

EPS estimate-$0.30

Next report

Aug 31, 2026 (In 2 days)

Revenue estimate$480.0K

EPS estimate-$0.24

Versus estimates

Revenue

Q1 2026$73.0KMiss by $387.0K

Q4 2025$60.0KMiss by $2.0M

Q3 2025$77.0KMiss by $6.7M Q2 2025$179.0KMiss by $16.3M Q1 2025$2.1MMiss by $6.9M Q4 2024$164.0KBeat by $64.0K

Diluted EPS

Q1 2026-$0.23Beat by $0.01

Q4 2025-$0.67Miss by $0.37

Q3 2025-$0.27Miss by $0.65 Q2 2025-$0.28Miss by $0.18 Q1 2025-$0.13Beat by $0.24 Q4 2024-$0.34Beat by $0.08

FAQ

When did CollPlant Biotechnologies report Q4 2025 earnings?: CollPlant Biotechnologies (CLGN) reported Q4 2025 earnings on March 26, 2026 before market open.
What were CollPlant Biotechnologies's Q4 2025 revenue and EPS?: CollPlant Biotechnologies reported revenue of $60.0K and eps of $-0.67 for Q4 2025.
Did CollPlant Biotechnologies beat estimates in Q4 2025?: Revenue missed the consensus estimate of $2.1M by $2.0M. EPS missed the consensus estimate of $-0.30 by $0.37.
How did CollPlant Biotechnologies's Q4 2025 results compare year-over-year?: Compared to the same quarter a year prior, revenue declined 63.4% from $164.0K a year earlier and eps declined 97.1% from $-0.34.

Ask the moment CollPlant Biotechnologies reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Harbor at dusk